Exogenous surfactant replacement in ARDS--one day, someday, or never?
Baudouin
Simon V
SV
University Department of Surgical Sciences and the Department of Anaesthesia, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000378:metabolism; D006801:Humans; D011650:Pulmonary Alveoli / Q000378:metabolism*; D037701:Pulmonary Surfactant-Associated Protein B / Q000378:metabolism; D037721:Pulmonary Surfactant-Associated Protein C / Q000378:metabolism / Q000627:therapeutic use*; D011663:Pulmonary Surfactants / Q000378:metabolism* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000378:metabolism; D017211:Treatment Failure
D037701:Pulmonary Surfactant-Associated Protein B; D037721:Pulmonary Surfactant-Associated Protein C; D011663:Pulmonary Surfactants; D011994:Recombinant Proteins; D015060:1,2-Dipalmitoylphosphatidylcholine